| Title | Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms. |
| Publication Type | Journal Article |
| Year of Publication | 2017 |
| Authors | Miranda, LFJR, Gomes, KB, Tito, PAL, Silveira, JN, Pianetti, GA, Byrro, RMD, Peles, PRH, Pereira, FH, Santos, TR, Assini, AG, Ribeiro, VV, Moraes, EN, Caramelli, P |
| Journal | J Alzheimers Dis |
| Volume | 55 |
| Issue | 2 |
| Pagination | 539-549 |
| Date Published | 2017 |
| ISSN | 1875-8908 |
| Abstract | The clinical response to donepezil in patients with mild and moderate dementia was investigated in relation to the drug plasma concentration and APOE and CYP2D6 polymorphisms. In a prospective naturalistic observational study, 42 patients with Alzheimer's disease (AD) and AD with cerebrovascular disease who took donepezil (10 mg) for 12 months were evaluated. Their DNA was genotyped, and the donepezil plasma concentrations were measured after 3, 6, and 12 months. Good responders scored ≥-1 on the Mini-Mental State Examination at 12 months in comparison to the baseline score. The study results indicated the good response pattern was influenced by the concentration of donepezil, but not by APOE and CYP2D6 polymorphisms. |
| DOI | 10.3233/JAD-160164 |
| Alternate Journal | J. Alzheimers Dis. |
| PubMed ID | 27716659 |
